Edwin S. Van Amersfoort - Publications

Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation.

Journal: Transplantation

Published: December 14, 2021

Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and neuroprotective properties in brain ischemia/reperfusion injury.

Journal: Brain, behavior, and immunity

Published: September 29, 2020

Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: July 23, 2019

Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice.

Journal: PloS one

Published: October 26, 2016

C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated Injury.

Journal: Shock (Augusta, Ga.)

Published: July 13, 2016

Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.

Journal: Journal of translational medicine

Published: May 17, 2016

Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 25, 2015

Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 28, 2014

Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: December 17, 2011

Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema.

Journal: British journal of clinical pharmacology

Published: November 25, 2011